Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer
Thyroid & Neuroendocrine / Endocrine Cancers
-
-
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
-
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
-
Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303
-
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
-
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
-
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
-
Family Communications After Genetic Testing
Categories
Alliance Committee
Browse by Year